Michael Shetzline, CMO,SVP,Head-Res&Drug: Ironwood Pharmaceuticals IRWD Sell · Filed 24/05/22

Trade details

Type: Insider sale
Amount: $104,025.6
Shares · price: 16,128 sh · $6.45 a share
Held after: 413,719 sh
Stock: Ironwood Pharmaceuticals IRWD
Person: Michael ShetzlineCMO,SVP,Head-Res&Drug
Trade date: 24/05/20
Filed: 24/05/22
Days to filing: 2 days

Sold 3.8% of holdings

Share of holding sold: 3.8%

Ironwood Pharmaceuticals trades, last 26 weeks

What else happened in Ironwood Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/04/20~24/06/19

Michael Shetzline's recent trades

Michael ShetzlineSVP, CMO, Head-Res&Drug
Planned saleIronwood Pharmaceuticals
Planned sale
Ironwood Pharmaceuticals
IRWD
$377.4K
83,306 sh
$377.4K
Filed 09/23
Traded 09/24
Michael ShetzlineSVP, CMO, Head-Res&Drug
SellIronwood Pharmaceuticals
Sell
Ironwood Pharmaceuticals
IRWD
$62.3K
17,012 sh
$62.3K
Filed 02/25
Traded 02/24
Michael ShetzlineSVP, CMO, Head-Res&Drug
SellIronwood Pharmaceuticals
Sell
Ironwood Pharmaceuticals
IRWD
$59.3K
15,570 sh
$59.3K
Filed 02/25
Traded 02/23
Michael ShetzlineSVP, CMO, Head-Res&Drug
Planned saleIronwood Pharmaceuticals
Planned sale
Ironwood Pharmaceuticals
IRWD
$138K
29,937 sh
$138K
Filed 02/20
Traded 02/23
Michael ShetzlineSVP, CMO, Head-Res&Drug
SellIronwood Pharmaceuticals
Sell
Ironwood Pharmaceuticals
IRWD
$72.6K
41,269 sh
$72.6K
Filed 25/02/12
Traded 25/02/10